Mangoceuticals Total Assets 2022-2024 | MGRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Mangoceuticals total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Mangoceuticals total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$76.8B
Chugai Pharmaceutical (CHGCY)	$66.9B
Takeda Pharmaceutical (TAK)	$42.4B
Sandoz Group AG (SDZNY)	$20.6B
Merck (MKKGY)	$20B
Astellas Pharma (ALPMY)	$17.7B
United Therapeutics (UTHR)	$16.6B
Summit Therapeutics (SMMT)	$16B
Neurocrine Biosciences (NBIX)	$15.3B
Shionogi (SGIOY)	$12.5B
Orion OYJ (ORINY)	$7.5B
Madrigal Pharmaceuticals (MDGL)	$7.1B
Stevanato Group S.p.A (STVN)	$6.5B
Corcept Therapeutics (CORT)	$6.4B
Hikma Pharmaceuticals Plc (HKMPF)	$5.9B
Ionis Pharmaceuticals (IONS)	$5.2B
Ono Pharmaceutical (OPHLF)	$4.9B
Grifols, S.A (GRFS)	$4.8B
Crinetics Pharmaceuticals (CRNX)	$3.7B
Catalyst Pharmaceuticals (CPRX)	$2.9B
Recursion Pharmaceuticals (RXRX)	$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
Centessa Pharmaceuticals (CNTA)	$2.2B
Soleno Therapeutics (SLNO)	$2.1B
Hypermarcas (HYPMY)	$1.9B
NewAmsterdam Pharma (NAMS)	$1.9B
Indivior (INDV)	$1.7B
BioCryst Pharmaceuticals (BCRX)	$1.7B
Evotec AG (EVO)	$1.5B
Guardian Pharmacy Services (GRDN)	$1.4B